CLDX logo

Celldex Therapeutics (CLDX) Revenue

Annual revenue:

$7.02M+$137.00K(+1.99%)
December 31, 2024

Summary

  • As of today (July 4, 2025), CLDX annual revenue is $7.02 million, with the most recent change of +$137.00 thousand (+1.99%) on December 31, 2024.
  • During the last 3 years, CLDX annual revenue has risen by +$2.37 million (+50.94%).
  • CLDX annual revenue is now -85.00% below its all-time high of $46.79 million, reached on December 31, 2010.

Performance

CLDX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

Quarterly revenue:

$695.00K-$480.00K(-40.85%)
March 31, 2025

Summary

  • As of today (July 4, 2025), CLDX quarterly revenue is $695.00 thousand, with the most recent change of -$480.00 thousand (-40.85%) on March 31, 2025.
  • Over the past year, CLDX quarterly revenue has increased by +$539.00 thousand (+345.51%).
  • CLDX quarterly revenue is now -98.16% below its all-time high of $37.72 million, reached on December 31, 2010.

Performance

CLDX Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

TTM revenue:

$7.56M+$539.00K(+7.68%)
March 31, 2025

Summary

  • As of today (July 4, 2025), CLDX TTM revenue is $7.56 million, with the most recent change of +$539.00 thousand (+7.68%) on March 31, 2025.
  • Over the past year, CLDX TTM revenue has increased by +$1.49 million (+24.49%).
  • CLDX TTM revenue is now -83.85% below its all-time high of $46.79 million, reached on December 31, 2010.

Performance

CLDX TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

CLDX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.0%+345.5%+24.5%
3 y3 years+50.9%+299.4%+82.5%
5 y5 years+96.5%-74.5%+71.9%

CLDX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+197.8%-83.2%+345.5%-24.2%+817.4%
5 y5-year-5.4%+197.8%-83.2%+354.3%-24.2%+817.4%
alltimeall time-85.0%+6920.0%-98.2%+119.0%-83.8%+383.8%

CLDX Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$695.00K(-40.9%)
$7.56M(+7.7%)
Dec 2024
$7.02M(+2.0%)
$1.18M(-63.2%)
$7.02M(-29.6%)
Sep 2024
-
$3.19M(+27.7%)
$9.98M(+20.2%)
Jun 2024
-
$2.50M(+1501.3%)
$8.30M(+36.7%)
Mar 2024
-
$156.00K(-96.2%)
$6.07M(-11.8%)
Dec 2023
$6.88M(+192.0%)
$4.13M(+172.3%)
$6.88M(+57.7%)
Sep 2023
-
$1.52M(+466.0%)
$4.37M(+34.1%)
Jun 2023
-
$268.00K(-72.3%)
$3.25M(+3.3%)
Mar 2023
-
$967.00K(-40.0%)
$3.15M(+33.6%)
Dec 2022
$2.36M(-49.3%)
$1.61M(+296.3%)
$2.36M(+118.6%)
Sep 2022
-
$407.00K(+149.7%)
$1.08M(+30.8%)
Jun 2022
-
$163.00K(-6.3%)
$824.00K(-80.1%)
Mar 2022
-
$174.00K(-47.9%)
$4.14M(-11.0%)
Dec 2021
$4.65M(-37.3%)
$334.00K(+118.3%)
$4.65M(-42.6%)
Sep 2021
-
$153.00K(-95.6%)
$8.10M(-6.0%)
Jun 2021
-
$3.48M(+408.0%)
$8.62M(+60.4%)
Mar 2021
-
$685.00K(-81.9%)
$5.37M(-27.5%)
Dec 2020
$7.42M(+107.6%)
$3.79M(+466.6%)
$7.42M(+64.1%)
Sep 2020
-
$668.00K(+183.1%)
$4.52M(+2.8%)
Jun 2020
-
$236.00K(-91.3%)
$4.40M(-9.8%)
Mar 2020
-
$2.73M(+207.6%)
$4.88M(+36.5%)
Dec 2019
$3.57M(-62.5%)
$887.00K(+62.5%)
$3.57M(-19.7%)
Sep 2019
-
$546.00K(-23.6%)
$4.45M(-8.2%)
Jun 2019
-
$715.00K(-49.8%)
$4.84M(-29.7%)
Mar 2019
-
$1.43M(-19.2%)
$6.89M(-27.7%)
Dec 2018
$9.54M(-25.2%)
$1.76M(+87.5%)
$9.54M(-15.1%)
Sep 2018
-
$941.00K(-65.9%)
$11.23M(-21.0%)
Jun 2018
-
$2.76M(-32.1%)
$14.21M(-7.0%)
Mar 2018
-
$4.07M(+17.7%)
$15.28M(+19.9%)
Dec 2017
$12.74M(+87.8%)
$3.46M(-11.9%)
$12.74M(+14.2%)
Sep 2017
-
$3.92M(+2.5%)
$11.16M(+18.0%)
Jun 2017
-
$3.83M(+149.6%)
$9.46M(+34.8%)
Mar 2017
-
$1.53M(-18.1%)
$7.02M(+3.4%)
Dec 2016
$6.79M(+23.8%)
$1.87M(-15.6%)
$6.79M(+1.2%)
Sep 2016
-
$2.22M(+59.8%)
$6.70M(+21.7%)
Jun 2016
-
$1.39M(+6.6%)
$5.51M(-12.5%)
Mar 2016
-
$1.30M(-27.2%)
$6.30M(+14.9%)
Dec 2015
$5.48M(+52.8%)
$1.79M(+74.6%)
$5.48M(+6.1%)
Sep 2015
-
$1.03M(-52.9%)
$5.17M(-1.4%)
Jun 2015
-
$2.18M(+348.1%)
$5.24M(+43.4%)
Mar 2015
-
$486.00K(-67.1%)
$3.66M(+2.0%)
Dec 2014
$3.59M(-12.8%)
$1.48M(+34.2%)
$3.59M(+31.4%)
Sep 2014
-
$1.10M(+86.0%)
$2.73M(+4.6%)
Jun 2014
-
$592.00K(+42.3%)
$2.61M(+23.4%)
Mar 2014
-
$416.00K(-32.9%)
$2.11M(-48.6%)
Dec 2013
$4.11M(-63.3%)
$620.00K(-36.7%)
$4.11M(-42.4%)
Sep 2013
-
$980.00K(+910.3%)
$7.14M(-23.0%)
Jun 2013
-
$97.00K(-96.0%)
$9.27M(-17.1%)
Mar 2013
-
$2.41M(-33.8%)
$11.18M(-0.2%)
Dec 2012
$11.20M(+20.9%)
$3.65M(+17.2%)
$11.20M(+12.1%)
Sep 2012
-
$3.11M(+55.0%)
$9.99M(+8.1%)
Jun 2012
-
$2.01M(-17.4%)
$9.24M(+0.6%)
Mar 2012
-
$2.43M(-0.0%)
$9.18M(-0.9%)
Dec 2011
$9.27M(-80.2%)
$2.43M(+3.0%)
$9.27M(-79.2%)
Sep 2011
-
$2.36M(+21.1%)
$44.55M(-0.1%)
Jun 2011
-
$1.95M(-22.4%)
$44.60M(-2.2%)
Mar 2011
-
$2.52M(-93.3%)
$45.60M(-2.6%)
Dec 2010
$46.79M(+208.3%)
$37.72M(+1466.5%)
$46.79M(+239.0%)
Sep 2010
-
$2.41M(-18.4%)
$13.80M(-10.5%)
Jun 2010
-
$2.95M(-20.5%)
$15.43M(+1.8%)
Mar 2010
-
$3.71M(-21.6%)
$15.16M(-0.1%)
Dec 2009
$15.18M(+103.6%)
$4.73M(+17.4%)
$15.18M(+13.0%)
Sep 2009
-
$4.03M(+50.1%)
$13.44M(+14.2%)
Jun 2009
-
$2.69M(-28.1%)
$11.76M(+6.6%)
Mar 2009
-
$3.73M(+24.9%)
$11.04M(+48.1%)
Dec 2008
$7.46M(+430.4%)
$2.99M(+26.8%)
$7.46M(+53.7%)
Sep 2008
-
$2.36M(+20.2%)
$4.85M(+75.7%)
Jun 2008
-
$1.96M(+1230.8%)
$2.76M(+96.0%)
Mar 2008
-
$147.40K(-61.6%)
$1.41M(+0.2%)
Dec 2007
$1.41M(+56.3%)
$383.40K(+42.5%)
$1.41M(-153.5%)
Sep 2007
-
$269.00K(-55.8%)
-$2.63M(+2.7%)
Jun 2007
-
$609.20K(+323.1%)
-$2.56M(-3.9%)
Mar 2007
-
$144.00K(-103.9%)
-$2.66M(-396.2%)
Dec 2006
$899.20K(-70.9%)
-$3.65M(-1177.2%)
$899.20K(-82.7%)
Sep 2006
-
$339.00K(-32.9%)
$5.19M(-8.9%)
Jun 2006
-
$505.50K(-86.4%)
$5.69M(-2.3%)
Mar 2006
-
$3.71M(+484.3%)
$5.82M(+88.6%)
Dec 2005
$3.09M
$634.30K(-25.1%)
$3.09M(-38.1%)
Sep 2005
-
$846.30K(+32.8%)
$4.99M(+6.8%)
Jun 2005
-
$637.20K(-34.3%)
$4.67M(-5.2%)
DateAnnualQuarterlyTTM
Mar 2005
-
$970.60K(-61.7%)
$4.93M(-29.5%)
Dec 2004
$6.86M(+48.0%)
$2.54M(+380.9%)
$6.99M(+31.6%)
Sep 2004
-
$527.50K(-40.9%)
$5.31M(-21.9%)
Jun 2004
-
$893.00K(-70.5%)
$6.80M(-2.7%)
Mar 2004
-
$3.03M(+253.4%)
$6.98M(+50.7%)
Dec 2003
$4.63M(-30.9%)
$857.70K(-57.4%)
$4.63M(+1.0%)
Sep 2003
-
$2.02M(+86.9%)
$4.59M(-35.7%)
Jun 2003
-
$1.08M(+58.2%)
$7.13M(+6.5%)
Mar 2003
-
$681.70K(-15.9%)
$6.70M(-0.1%)
Dec 2002
$6.70M(+100.4%)
$810.80K(-82.2%)
$6.70M(-1.8%)
Sep 2002
-
$4.56M(+609.5%)
$6.83M(+128.0%)
Jun 2002
-
$642.80K(-7.0%)
$2.99M(-5.8%)
Mar 2002
-
$690.90K(-26.2%)
$3.18M(-5.0%)
Dec 2001
$3.35M(+338.4%)
$935.70K(+29.0%)
$3.35M(+23.4%)
Sep 2001
-
$725.50K(-12.1%)
$2.71M(+26.7%)
Jun 2001
-
$825.80K(-3.9%)
$2.14M(+45.8%)
Mar 2001
-
$859.00K(+184.8%)
$1.47M(+92.4%)
Dec 2000
$763.20K(-48.6%)
$301.60K(+96.0%)
$763.20K(+71.5%)
Sep 2000
-
$153.90K(0.0%)
$445.10K(-24.7%)
Jun 2000
-
$153.90K(+0.1%)
$591.20K(-54.0%)
Mar 2000
-
$153.80K(-1032.1%)
$1.29M(-10.2%)
Dec 1999
$1.48M(-31.0%)
-$16.50K(-105.5%)
$1.43M(-42.7%)
Sep 1999
-
$300.00K(-64.6%)
$2.50M(-3.8%)
Jun 1999
-
$847.90K(+182.6%)
$2.60M(+26.7%)
Mar 1999
-
$300.00K(-71.4%)
$2.05M(-4.7%)
Dec 1998
$2.15M(+80.4%)
$1.05M(+162.6%)
$2.15M(+44.1%)
Sep 1998
-
$400.00K(+33.3%)
$1.49M(+25.2%)
Jun 1998
-
$300.00K(-25.0%)
$1.19M(-25.1%)
Mar 1998
-
$400.00K(+2.0%)
$1.59M(+23.2%)
Dec 1997
$1.19M(+8.4%)
$392.10K(+292.1%)
$1.29M(+7.7%)
Sep 1997
-
$100.00K(-85.7%)
$1.20M(0.0%)
Jun 1997
-
$700.00K(+600.0%)
$1.20M(+71.4%)
Mar 1997
-
$100.00K(-66.7%)
$700.00K(-41.7%)
Dec 1996
$1.10M(-72.5%)
$300.00K(+200.0%)
$1.20M(-33.3%)
Sep 1996
-
$100.00K(-50.0%)
$1.80M(-28.0%)
Jun 1996
-
$200.00K(-66.7%)
$2.50M(-28.6%)
Mar 1996
-
$600.00K(-33.3%)
$3.50M(-14.6%)
Dec 1995
$4.00M(-42.9%)
$900.00K(+12.5%)
$4.10M(-2.4%)
Sep 1995
-
$800.00K(-33.3%)
$4.20M(-14.3%)
Jun 1995
-
$1.20M(0.0%)
$4.90M(-16.9%)
Mar 1995
-
$1.20M(+20.0%)
$5.90M(-15.7%)
Dec 1994
$7.00M(-22.2%)
$1.00M(-33.3%)
$7.00M(-14.6%)
Sep 1994
-
$1.50M(-31.8%)
$8.20M(-6.8%)
Jun 1994
-
$2.20M(-4.3%)
$8.80M(-4.3%)
Mar 1994
-
$2.30M(+4.5%)
$9.20M(+1.1%)
Dec 1993
$9.00M(+36.4%)
$2.20M(+4.8%)
$9.10M(+31.9%)
Sep 1993
-
$2.10M(-19.2%)
$6.90M(-10.4%)
Jun 1993
-
$2.60M(+18.2%)
$7.70M(+2.7%)
Mar 1993
-
$2.20M(-24.1%)
$7.50M(-30.6%)
Dec 1992
$6.60M(-25.8%)
-
-
Oct 1992
-
$2.90M(+20.8%)
$10.80M(+12.5%)
Jul 1992
-
$2.40M(0.0%)
$9.60M(+7.9%)
Apr 1992
-
$2.40M(-22.6%)
$8.90M(-1.1%)
Apr 1992
$8.90M(-12.7%)
-
-
Jan 1992
-
$3.10M(+82.4%)
$9.00M(+5.9%)
Oct 1991
-
$1.70M(0.0%)
$8.50M(-9.6%)
Jul 1991
-
$1.70M(-32.0%)
$9.40M(-7.8%)
Apr 1991
$10.20M(-6.4%)
$2.50M(-3.8%)
$10.20M(-8.1%)
Jan 1991
-
$2.60M(0.0%)
$11.10M(-7.5%)
Oct 1990
-
$2.60M(+4.0%)
$12.00M(+1.7%)
Jul 1990
-
$2.50M(-26.5%)
$11.80M(+3.5%)
Apr 1990
$10.90M(+39.7%)
$3.40M(-2.9%)
$11.40M(+10.7%)
Jan 1990
-
$3.50M(+45.8%)
$10.30M(+18.4%)
Oct 1989
-
$2.40M(+14.3%)
$8.70M(+6.1%)
Jul 1989
-
$2.10M(-8.7%)
$8.20M(+5.1%)
Apr 1989
$7.80M(+69.6%)
$2.30M(+21.1%)
$7.80M(+23.8%)
Jan 1989
-
$1.90M(0.0%)
$6.30M(+6.8%)
Oct 1988
-
$1.90M(+11.8%)
$5.90M(+13.5%)
Jul 1988
-
$1.70M(+112.5%)
$5.20M(+15.6%)
Apr 1988
$4.60M(+109.1%)
$800.00K(-46.7%)
$4.50M(+15.4%)
Jan 1988
-
$1.50M(+25.0%)
$3.90M(+21.9%)
Oct 1987
-
$1.20M(+20.0%)
$3.20M(+23.1%)
Jul 1987
-
$1.00M(+400.0%)
$2.60M(+44.4%)
Apr 1987
$2.20M(+2100.0%)
$200.00K(-75.0%)
$1.80M(+12.5%)
Jan 1987
-
$800.00K(+33.3%)
$1.60M(+77.8%)
Oct 1986
-
$600.00K(+200.0%)
$900.00K(+125.0%)
Jul 1986
-
$200.00K(+100.0%)
$400.00K(+33.3%)
Apr 1986
$100.00K
-
-
Jan 1986
-
$100.00K(0.0%)
$300.00K(+50.0%)
Oct 1985
-
$100.00K(0.0%)
$200.00K(+100.0%)
Jul 1985
-
$100.00K
$100.00K

FAQ

  • What is Celldex Therapeutics annual revenue?
  • What is the all time high annual revenue for Celldex Therapeutics?
  • What is Celldex Therapeutics annual revenue year-on-year change?
  • What is Celldex Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for Celldex Therapeutics?
  • What is Celldex Therapeutics quarterly revenue year-on-year change?
  • What is Celldex Therapeutics TTM revenue?
  • What is the all time high TTM revenue for Celldex Therapeutics?
  • What is Celldex Therapeutics TTM revenue year-on-year change?

What is Celldex Therapeutics annual revenue?

The current annual revenue of CLDX is $7.02M

What is the all time high annual revenue for Celldex Therapeutics?

Celldex Therapeutics all-time high annual revenue is $46.79M

What is Celldex Therapeutics annual revenue year-on-year change?

Over the past year, CLDX annual revenue has changed by +$137.00K (+1.99%)

What is Celldex Therapeutics quarterly revenue?

The current quarterly revenue of CLDX is $695.00K

What is the all time high quarterly revenue for Celldex Therapeutics?

Celldex Therapeutics all-time high quarterly revenue is $37.72M

What is Celldex Therapeutics quarterly revenue year-on-year change?

Over the past year, CLDX quarterly revenue has changed by +$539.00K (+345.51%)

What is Celldex Therapeutics TTM revenue?

The current TTM revenue of CLDX is $7.56M

What is the all time high TTM revenue for Celldex Therapeutics?

Celldex Therapeutics all-time high TTM revenue is $46.79M

What is Celldex Therapeutics TTM revenue year-on-year change?

Over the past year, CLDX TTM revenue has changed by +$1.49M (+24.49%)
On this page